Research Leadership: Michael Brattain, Ph.D.

January 30, 2015

Image with caption: Michael Brattain, Ph.D.

Michael Brattain, Ph.D.

This profile is part of a series to highlight the researchers who will be honored Feb. 2 at a ceremony for UNMC's 2014 Scientist Laureate, Research Leadership, Distinguished Scientist and New Investigator Award recipients.

You're invited!

The campus is invited to attend the ninth annual Distinguished Scientist Ceremony at 4 p.m. Monday, Feb. 2, at the Durham Research Center Auditorium. Each year, faculty members who have made significant contributions to the research enterprise at UNMC are recognized by the leadership and their peers. This year, 25 researchers and one community volunteer will be recognized for their accomplishments. The Scientist Laureate, Tatiana Bronich, Ph.D., will deliver an address to the assembly and a reception honoring the awardees will be held immediately following the award ceremony.

  • Name: Michael Brattain, Ph.D.
  • Title: Professor and associate director, Eppley Institute for Research in Cancer and associate director for basic science and program leader, Fred & Pamela Buffett Cancer Center
  • Joined UNMC: June 1, 2007
  • Hometown: Ponca City, Oklahoma

Describe your research briefly in layman's terms.
We study the mechanisms for metastasis in colon cancer in order to find new targets for treatment.

How does your research contribute to science and/or health care?
We identify new signaling pathways. In identifying these pathways, we contribute to medicine by identifying targets that work against metastatic colon cancer.

List three things few people know about you.

  • I just learned how to text this year from my 12 year-old daughter.
  • I have consistently had NIH grants since 1977.
  • I am not a grandfather.


Fill out the following and your comment will post once it has been approved.

Name (Required)

Email (Required)

Thank you, your comment will appear below once it has been approved.